Found 5 matching trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
PHASE2A randomized, double-blind study to assess the safety, tolerability, PK and...
Location
National Research Institute - Gardena
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
PHASE3A Randomized, Double-Blind, Placebo-controlled, Phase III Study to Evaluate...
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
PHASE2A phase II Study of CS0159 in Chinese patients with PSC(Primary Sclerosing ...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
PHASE2A phase II study to evaluate safety, tolerability and efficacy of CS0159 in...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects
PHASE1This is a phase I clinical bridging trial, randomized, double-blind, placeb...
Location
Shanghai Xuhui Central Hospital